Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Cancer ; 7: 65, 2007 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-17433113

RESUMO

BACKGROUND: Evaluation of the clinical efficacy and tolerance of metronomic chemotherapy as salvage therapy in a young patient with advanced, platinum resistant, ovarian carcinoma and bad performance status. CASE PRESENTATION: We tried palliative chemotherapy with daily low dose oral cyclophosphamide with a patient suffering from stage IIIC ovarian cancer that responded to daily cyclophosphamide (CTX) after no response to chemotherapy with paclitaxel and carboplatin as first line and progression after second line with topotecan. The progression-free survival time on daily low dose oral cyclophosphamide treatment was 65 months without side effects. She was well during the chemotherapy and lived a normal working and social life. CONCLUSION: We think that use of low dose of oral CTX should be investigated further as a strategy against tumour progression after standard chemotherapy in patients who are platinum resistant with poor performance status.


Assuntos
Antineoplásicos Alquilantes/administração & dosagem , Ciclofosfamida/administração & dosagem , Cistadenocarcinoma Seroso/tratamento farmacológico , Neoplasias Ovarianas/tratamento farmacológico , Cuidados Paliativos , Terapia de Salvação , Adulto , Antineoplásicos Alquilantes/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carboplatina/administração & dosagem , Neoplasias do Colo/complicações , Neoplasias do Colo/secundário , Neoplasias do Colo/cirurgia , Colostomia , Ciclofosfamida/uso terapêutico , Cistadenocarcinoma Seroso/secundário , Cistadenocarcinoma Seroso/cirurgia , Intervalo Livre de Doença , Esquema de Medicação , Avaliação de Medicamentos , Resistencia a Medicamentos Antineoplásicos , Epoetina alfa , Eritropoetina/uso terapêutico , Evolução Fatal , Feminino , Seguimentos , Hemorragia/etiologia , Humanos , Obstrução Intestinal/etiologia , Avaliação de Estado de Karnofsky , Laparotomia , Neoplasias Ovarianas/patologia , Ovariectomia , Paclitaxel/administração & dosagem , Neoplasias Peritoneais/secundário , Proteínas Recombinantes , Topotecan/administração & dosagem , Neoplasias da Bexiga Urinária/complicações , Neoplasias da Bexiga Urinária/secundário , Vitaminas/uso terapêutico
2.
Gynecol Oncol ; 103(1): 234-7, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16595145

RESUMO

OBJECTIVE: Primary squamous carcinoma of the vagina in young woman is extremely rare. Conservative management of both sexual and reproductive function poses challenging problems to gynecologic oncologists. METHODS: Between January 2001 and December 2004, four women under 40, nulliparous, with squamous cell carcinoma of the upper third of the vagina, at FIGO Stage I were submitted to conservative surgery of the reproductive/sexual function at our Institution. After written informed consent was obtained, conservative surgical treatment consisting of radical tumorectomy with pelvic lymphadenectomy, in three patients, and partial hemi-vaginectomy plus homolateral paracolpectomy/parametrectomy with pelvic lymphadenectomy, in the forth patient, was carried out. RESULTS: Mean operative time of conservative surgical treatment was 161 min. No intraoperative or postoperative complications were observed. In one patient, definitive pathologic examination revealed microscopic involvement of the paracolpium. Thus, after carrying out laparoscopic ovarian transposition, adjuvant radiotherapy (RT), consisting of pulsed-dose rate brachytherapy and external RT, was delivered in this woman. After a follow-up time of 51, 45, 21 and 9 months, respectively, all patients are regularly menstruating, sexually active and clinically free of disease. CONCLUSION: To our knowledge, this is the first report showing the feasibility and the efficacy of conservative surgery of reproductive and sexual function in young woman with vaginal carcinoma. A larger number of patients and a longer follow-up are needed to validate the safety of this approach.


Assuntos
Carcinoma de Células Escamosas/cirurgia , Neoplasias Vaginais/cirurgia , Adulto , Carcinoma de Células Escamosas/patologia , Feminino , Seguimentos , Humanos , Menstruação , Estadiamento de Neoplasias , Qualidade de Vida , Reprodução , Comportamento Sexual , Neoplasias Vaginais/patologia
3.
J Pediatr Adolesc Gynecol ; 18(6): 419-22, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16338609

RESUMO

BACKGROUND: Mucinous cystadenoma of the ovary constitutes about 15% of ovarian tumors. It is more common in women between 20 and 40, but is rare in teenagers and exceptional in pre-menstrual girls. Malignant transformation is possible in 5-10% of cases. Spontaneous or iatrogenic breaks are more common. It makes the different diagnosis of pseudomixoma peritonei more difficult. CASE REPORT: A 13-year-old girl came to the National Cancer Institute "Regina Elena" of Rome, with increasing abdominal distension over 2 months. The abdominal mass was removed and a left salpingo-oophorectomy was performed. Histological examination of the mass revealed a 40-cm diameter mucinous cystadenoma of the ovary. CONCLUSION: The rapid enlargement of the ovarian mass, the young age and the difficulty of certain pre-operative diagnosis, make this case interesting. Management of this pathology and fertility-conserving treatment need careful follow-up because of the possibility of recurrence in the remaining ovary.


Assuntos
Cistadenoma Mucinoso/diagnóstico , Neoplasias Ovarianas/diagnóstico , Adolescente , Cistadenoma Mucinoso/patologia , Cistadenoma Mucinoso/cirurgia , Diagnóstico Diferencial , Tubas Uterinas/cirurgia , Feminino , Procedimentos Cirúrgicos em Ginecologia , Humanos , Neoplasias Ovarianas/patologia , Neoplasias Ovarianas/cirurgia , Ovariectomia , Pseudomixoma Peritoneal/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...